Filtros de búsqueda

Lista de obras de

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy

artículo científico publicado en 2017

A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors

artículo científico publicado en 2005

A diagnostic strategy for breast calcifications based on a long-term follow-up of 615 lesions

artículo científico publicado en 2018

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

artículo científico publicado en 2019

A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study) ⬇️

artículo científico publicado el 26 de julio de 2012

A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients

artículo científico publicado en 2017

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

scientific article published on 13 March 2020

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer

scientific article published on 17 January 2020

A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer ⬇️

artículo científico publicado el 30 de mayo de 2013

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PREC

scientific article published on 01 September 2018

Abstract PS2-32: Incidental malignant findings on pre-admission chest computed tomography scan for coronavirus disease screening in patients with breast cancer or other cancers

artículo científico publicado en 2021

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype

artículo científico publicado en 2016

Activation of PI3K/Akt signaling and hormone resistance in breast cancer

scientific article published on 01 January 2006

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

artículo científico publicado en 2017

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial

artículo científico publicado en 2021

Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence

scientific article published on 02 September 2019

An overview of the Japan Breast Cancer Research Group (JBCRG) activities ⬇️

artículo científico publicado el 15 de marzo de 2013

Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3

artículo científico publicado en 2020

Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.

artículo científico publicado en 2014

Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer

artículo científico publicado en 2004

Aromatase inhibitors with or without luteinizing hormone-releasing hormone agonist for metastatic male breast cancer: report of four cases and review of the literature.

artículo científico publicado en 2016

Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B

artículo científico publicado en 2005

Brain metastasis of breast cancer

artículo científico publicado en 2004

Breast castleman disease

artículo científico publicado en 2020

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.

artículo científico publicado en 2018

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

artículo científico publicado en 2019

Characteristics of adverse events of endocrine therapies among older patients with breast cancer

scientific article published on 07 February 2019

Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer

artículo científico publicado en 2017

Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients

scientific article published on 21 March 2020

Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer

scientific article published on 01 August 2018

Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement.

artículo científico publicado en 2014

Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era

scientific article published on 21 April 2018

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer

scientific article published on 04 February 2020

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy ⬇️

artículo científico publicado en 2016

Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis

scientific article published on 29 September 2020

Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval.

artículo científico publicado en 2004

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG.

artículo científico publicado en 2014

Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancer

scientific article published on 01 January 2002

Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer

artículo científico publicado en 2002

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

artículo científico publicado en 2019

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

artículo científico publicado en 2017

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized cont

artículo científico publicado en 2020

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review

artículo científico publicado en 2017

Cytogenetic analysis of metaplastic squamous cell carcinoma of the breast inter- and intratumoral heterogeneity

artículo científico publicado en 2017

DNA aneuploidy in relation to the combination of analysis of estrogen receptor, progesterone receptor, p53 protein and epidermal growth factor receptor in 498 breast cancers

artículo científico publicado en 2002

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

artículo científico publicado en 2005

Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting

artículo científico publicado en 2015

Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study

artículo científico publicado el 1 de mayo de 2012

Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer

artículo científico publicado en 2007

Efficacy of Adjuvant Combination Therapy With Trastuzumab and Chemotherapy in HER2-positive Early Breast Cancer: A Single Institutional Cohort Study from Clinical Practice

artículo científico publicado en 2020

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

artículo científico publicado en 2013

Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure

artículo científico publicado en 2015

Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)

artículo científico publicado en 2020

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective study

artículo científico publicado en 2016

Erratum to: Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients

artículo científico publicado en 2015

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

artículo científico publicado en 2013

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

scientific article published on 06 December 2019

Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

artículo científico publicado en 2017

First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer.

artículo científico publicado en 2017

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers

scientific article published on 12 April 2019

Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers

artículo científico publicado en 2002

For choosing axillary treatment, and adjuvant hormonal treatment

artículo científico publicado en 2015

Frequent loss of heterozygosity but rare microsatellite instability in oesophageal cancer in Japanese and Chinese patients

artículo científico publicado en 2004

Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: a Japanese study

artículo científico publicado en 2004

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer

artículo científico publicado en 2022

Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature

scientific article published on 19 November 2019

High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)

artículo científico publicado el 1 de marzo de 2012

Histological classification of invasive ductal carcinoma and the biological parameters in breast cancer

artículo científico publicado en 2003

Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer

artículo científico publicado en 2016

Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy

artículo científico publicado en 2020

Impact of Visceral Metastasis on Efficacy of Fulvestrant in Patients with Hormone Receptor-positive Recurrent Breast Cancer

artículo científico publicado en 2018

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial.

artículo científico publicado en 2018

Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.

artículo científico publicado en 2016

Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes

artículo científico publicado en 2005

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study

artículo científico publicado en 2020

Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations

artículo científico publicado en 2017

N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study

scientific article published on 14 January 2020

Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study

scientific article published on 14 June 2018

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study

scientific article published on 30 July 2019

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

scientific article published on 24 May 2019

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients

artículo científico publicado en 2015

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

artículo científico publicado en 2020

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients

artículo científico publicado en 2018

Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: a Japanese phase II study.

artículo científico publicado en 2018

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients

artículo científico publicado en 2018

Palbociclib-letrozole as first-line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study

artículo científico publicado en 2020

Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis

artículo científico publicado en 2002

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer

artículo científico publicado en 2017

Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer

artículo científico publicado en 2020

Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer.

artículo científico publicado en 2014

Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer

artículo científico publicado en 2020

Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

artículo científico publicado en 2017

Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm

artículo científico publicado en 2018

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer

artículo científico publicado en 2016

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel

artículo científico publicado en 2018

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.

artículo científico publicado en 2012

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome

scientific article published on 12 June 2020

Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study

artículo científico publicado en 2013

Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer

artículo científico publicado en 2002

Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast

artículo científico publicado en 2018

Prognostic significance of histological therapeutic effect in preoperative chemotherapy for breast cancer

scientific article published on 27 November 2015

Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG.

artículo científico publicado en 2013

Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer

artículo científico publicado en 2003

Prognostic significance of the combination of biological parameters in breast cancer

scientific article published on 01 January 2003

Prognostic value of c-erbB2 expression in breast cancer

artículo científico publicado en 2002

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

artículo científico publicado en 2002

Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer

artículo científico publicado en 2003

Prospective cohort study: whether or not patients benefit from participation itself in randomized-controlled trials (SELECT BC ECO).

artículo científico publicado en 2014

Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study

artículo científico publicado en 2020

Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

artículo científico publicado en 2017

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

artículo científico publicado en 2020

Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital

artículo científico publicado en 2020

Sensitization of chemotherapy by anti-HER.

artículo científico publicado en 2004

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer

artículo científico publicado en 2016

Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02 ⬇️

artículo científico publicado el 15 de marzo de 2012

Surgical excision without whole breast irradiation for complete resection of ductal carcinoma in situ identified using strict, unified criteria

artículo científico publicado en 2016

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational

scientific article published on 05 July 2018

Survival in Cytologically Proven Node-Positive Breast Cancer Patients with Nodal Pathological Complete Response after Neoadjuvant Chemotherapy

scientific article published on 15 September 2020

The Efficacy and Safety of FSK0808, Filgrastim Biosimilar: A Multicenter, Non-randomized Study in Japanese Patients with Breast Cancer ⬇️

artículo científico publicado el 14 de julio de 2013

The Expression Level of PD-L1 (CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer

artículo científico publicado en 2020

The association between Akt activation and resistance to hormone therapy in metastatic breast cancer

artículo científico publicado en 2006

The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution

artículo científico publicado en 2020

The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.

artículo científico publicado en 2017

The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial

scientific article published on 26 February 2019

Tolerability of Therapies Recommended for the Treatment of Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer

artículo científico publicado en 2016

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inf

artículo científico publicado en 2020

Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype

artículo científico publicado en 2014

Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.

artículo científico publicado en 2017

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan

artículo científico publicado en 2014

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities

scientific article published on 12 August 2019

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center

artículo científico publicado en 2020

Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer

artículo científico publicado en 2012

[Clinical implementation of the immunohistochemical intrinsic subtypes of breast cancer]

scientific article published on 01 September 2012

p53 protein accumulation in multiple oesophageal squamous cell carcinoma: relationship to risk factors

artículo científico publicado en 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda